Preparation, characterization and anticancer applications of HAase from Pedobacter heparinus Authors: Bo Dou, Ruiqi Wu, Xiaolai Ma, Changhua Hu, Xiaoqun Duan Published: 2026 ABSTRACT Hyaluronidase (HAase) is an enzyme capable of degrading hyaluronic acid (HA). In anti-tumor therapy, HAase can enhance the efficacy of anti-cancer drugs by regulating the tumor microenvironment and overcoming drug delivery barriers, and it can also be used directly to inhibit tumor growth. In this study, we identified a previously uncharacterized HAase (Ph-HAase) from Pedobacter heparinus. After purification, the enzyme was obtained with a 43.08% recovery, a 47.5-fold purification, and a specific activity of 32.32 IU/mg. SDS-PAGE and LC-MS analyses revealed that the molecular weight of Ph-HAase was 79.6 kDa. Ph-HAase exhibited excellent stability at temperatures below 30 °C and within the pH range of 6.5 to 7.5. The enzyme activity was found to be relatively high at pH 6.5 and 45℃. Although HA served as the preferred substrate, Ph-HAase also exhibited degradative activity toward Chondroitin Sulfate (CS) and Dermatan Sulfate (DS). Notably, we found that Ph-HAase induced apoptosis in melanoma B16F10 cells via the mitochondrial pathway, characterized by loss of membrane potential and ROS accumulation, and affected the expression of apoptosis-related genes and proteins. In vivo studies further confirmed its anti-melanoma effect. This study is the first to report HAase derived from P. heparinus and to demonstrate its potential for melanoma treatment.Supplementary InformationThe online version contains supplementary material available at https://doi.org/10.1186/s12885-026-16378-4. Introduction Hyaluronidase (HAase) is a kind of lyases widely distributed in nature, that degrades hyaluronic acid (HA) by acting on β-1,3 or β-1,4 glycosidic bonds [1]. First discovered by Duran-Reynals in 1929 and referred to as the “spreading factor” [2]. In 1940, the enzyme was formally named HAase by Meyer et al. [3]. Since then, HAase has gradually been discovered in various tissues of the human body and in many organisms, playing a crucial role in physiological and pathological processes [4]. Currently, the sources of HAase available on the market mainly include bovine and ovine testicles as well as recombinant human HAase [5]. However, the animal-derived HAase carries the risk of transmitting animal-source diseases. Recombinant human HAase has a better safety profile but typically shows lower degradation activity towards HA [6]. Therefore, it is necessary to develop new types of HAase to mitigate the risk of animal-source diseases and overcome the limitations of the low activity of recombinant human enzymes. HAase is widely used across various fields, including surgery, aesthetic medicine, immunology, and oncology [5]. In anti-tumor research, it has been found that this enzyme exhibits significant anti-cancer potential against pancreatic cancer, breast cancer, liver cancer, gastric cancer, and prostate cancer [7–11]. Studies have shown that HA expression in tumor tissues is generally high. As a major component of the extracellular matrix (ECM), HA’s high hydration property readily forms a dense gel, hindering drug diffusion [12]. By hydrolysis with HAase, reducing ECM density could enhance the direct penetration of drugs [12, 13]. When HA is degraded, bound water molecules can be released, reducing the volume of the tumor ECM and lowering tumor interstitial fluid pressure (TIFP), thereby promoting blood perfusion and drug delivery to deeper tumor regions [13]. In addition, HA and CD44 interaction promotes epidermal growth factor receptor signaling pathways, thereby driving tumor cell growth, migration, and chemotherapy resistance [14]. HAase can degrade HA and interfere with the HA-CD44 interaction, thereby inhibiting various types of cancers with high HA expression [15]. Avsharian et al. [8] enhanced the efficacy of chemotherapy drugs for pancreatic cancer by expressing HAase through recombinant Escherichia coli. Ebraheem et al. [7] separated and purified HAase (65 kDa) and found that it significantly increased the expression of tumor suppressor genes p53, caspase-9, and caspase-3 in breast cancer cells (MDA). A diverse range of HAases has been reported to date, including enzymes of animal origin—such as those derived from bovine and ovine testes [16, 17], porcine sperm [18], and snake venom [19] —as well as microbial HAases from Streptococcus pneumoniae, Clostridium perfringens, Brucella intermedia, Staphylococcus aureus, among others [7, 19–22]. Most of the HAase derived from microorganisms is obtained by fermenting bacterial strains [7, 23]. This process is influenced by various factors, including the composition of the culture medium, pH value, fermentation time, and fermentation temperature [23]. Therefore, optimizing these indicators can enhance enzyme expression in the bacterial strain. The identification and characterization of HAase were carried out through ammonium sulfate precipitation, membrane technologies, and chromatographic techniques [24]. Melanoma is a highly immunogenic and invasive malignant tumour originating from the transformation of melanocytes or their precursors [25]. As the incidence of melanoma has increased in recent years, traditional surgical treatment cannot completely cure melanoma and improve patient survival [26]. Current management of melanoma now encompasses a combination of immunotherapy, targeted therapy, radiotherapy, and novel experimental therapies [27]. However, developing successful therapeutic approaches requires a precise understanding of the mechanisms underlying melanoma initiation and progression [28]. The mitochondrial-mediated intrinsic apoptotic pathway is a key regulatory axis for inducing melanoma cell death, and the loss of mitochondrial membrane potential and the excessive accumulation of reactive oxygen species (ROS) are core events that trigger this apoptotic process [29, 30]. Heparanase, a homolog of HAase, has been shown to exert dual regulatory effects on melanoma progression by remodeling the extracellular matrix and regulating intracellular gene expression [31, 32]. However, the anti-tumor activity and underlying mechanism of HAase derived from P. heparinus in melanoma have not been reported to date. Although some glycosaminoglycan lyases from P. heparinus have been found to possess catalytic promiscuity for glycosaminoglycan degradation [33], their potential application in melanoma therapy remains unknown. In this context, exploring the mechanism of action of Ph-HAase in treating melanoma through the mitochondrial pathway is of great significance for the development of novel anti-melanoma drugs. The main objective of this study is to increase the yield of Ph-HAase through fermentation, followed by purification and characterization, and then apply it in the treatment of melanoma. Materials and methods Materials P. heparinus (DSM 2366) was obtained from the German Collection of Microorganisms and Cell Cultures (DSMZ, Darmstadt, Germany). The following materials were used in this study: HA (Source of Streptococcus, 20–40 kDa, Shaanxi Bolin Biotechnology, China); tryptone, beef meal, and nutrient agar (Oxoid, UK); Cellufine™ Sulfate (CHISSO, Japan); UniGel-30CM (Cytiva, USA); the human ovarian cancer cell line SK-OV-3, human liver cancer cell line HepG2, human lung adenocarcinoma drug-resistant cell line A549, human bladder cancer cell line T-24, melanoma B16F10 cell line, and human immortalized keratinocyte line HaCaT (Shanghai Cell Bank, China); Coomassie Brilliant Blue, PMSF, DTT (Sigma, USA); and electrophoresis molecular weight marker kits(MBI, New England). Gene JET RNA Purification Kit, (Thermo Scientific, USA). All other chemical reagents (Shanghai Aladdin, China). Optical measurements were carried out using a UV-2100 spectrophotometer (Unico, China). Fermentation was performed using an incubator shaker (Xinrui Automatic Apparatus, China). ELx800 Epoch Full-Waveband Multi-Function Enzyme-Labeling (Biotek, USA). U3000 UHPLC Ultra High Performance Liquid Chromatograph and Q Exactive High-Resolution Mass Spectrometer (Thermo, USA). Inverted fluorescence microscope (Guangzhou Mingmei Optoelectronic Technology, China). Real-time fluorescence quantitative PCR instrument (Bio-Rad, USA). NovoCyte Quanteon quantitative flow cytometer (Agilent Technologies, USA). Enzyme assays Ph-HAase catalyzes the degradation of hyaluronan via a β-elimination mechanism, a characteristic of polysaccharide lyases (EC 4.2.2.1). This reaction introduces a C4–C5 unsaturated double bond in the non-reducing terminal glucuronic acid residue, which exhibits a characteristic absorption maximum at 232 nm. Therefore, the enzymatic activity of Ph-HAase was monitored spectrophotometrically by measuring the increase in absorbance at 232 nm (OD₂₃₂) [34]. One unit (IU) of Ph-HAase activity is defined as the amount of enzyme that produces 1 µmol of unsaturated disaccharide per minute under the assay conditions, calculated using the molar extinction coefficient of Δ-4,5-unsaturated uronic acid (ε₂₃₂ = 5,500 M⁻¹·cm⁻¹) [34]. Briefly, 2.5 mL of HA substrate (0.1 g HA dissolved in 100 mL of 10 mM Tris-HCl, pH 7.0) was added to a quartz cuvette, followed by 20 µL of Ph-HAase, and the mixture was mixed well. The assay was performed by monitoring the absorbance at 232 nm for 1 min at room temperature using a UV-2150 spectrophotometer (Unicosh, Shanghai, China). The enzyme activity was calculated according to the following equation derived from the Beer-Lambert law:\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$IU=\frac{\vartriangle{A}\times\;V_{total}\times\;10^6\times\;D}{\epsilon\times\;l\times\;t\times\;V_{enzyme}}$$\end{document} where ΔA is the change in absorbance over the reaction time (min⁻¹), \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\:{\mathrm{V}}_{\mathrm{total}}$$\end{document} is the total reaction volume (2.52 mL = 0.00252 L), \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\:\mathrm{D}$$\end{document} is the dilution factor of the enzyme solution, \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\:\mathrm{ε}$$\end{document} is the molar extinction coefficient (5,500 M⁻¹·cm⁻¹), \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\:\mathrm{l}$$\end{document} is the path length (1 cm), \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\:\mathrm{t}$$\end{document} is the reaction time (1 min), and \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\:{\mathrm{V}}_{\mathrm{enzyme}}$$\end{document} is the volume of enzyme added (0.02 mL). Fermentation process optimization of Ph-HAase Using the enzyme activity of Ph-HAase produced by the strain as an indicator, single-factor experiments were first conducted on the fermentation conditions by varying the inducer HA concentration (0.1%, 0.15%, 0.2%, 0.25%, 0.3%) in the culture medium; the concentration of tryptone (1.0%, 1.25%, 1.5%, 1.75%, 2.0%); Na2HPO4·12H2O concentration (0.1%, 0.3%, 0.5%, 0.7%, 0.9%); CaCl2concentration (0.01%, 0.03%, 0.05%, 0.07%, 0.09%); initial pH of the medium (6.5, 7.0, 7.5, 8.0, 8.5); inoculum volume (3%, 4%, 5%, 6%, 7%); fermentation time (0 h, 12 h, 24 h, 36 h, 48 h, 60 h, 72 h); fermentation temperature (12 °C, 15 °C, 18 °C, 21 °C, 24 °C, 27 °C, 30 °C); and loading volume (20%, 30%, 40%, 50%, 60%, 70%, 80%), etc. Based on the single-factor experiments, a four-factor, three-level orthogonal experiment was conducted to determine the optimal fermentation conditions for Ph-HAase production by the strain [35–37]. Please refer to the supplementary data for the orthogonal experimental results. Preparation of crude enzyme solution Based on the fermentation optimization results, which indicated that the optimal medium consisted of 2% tryptone, 0.05% CaCl2, 0.15% HA, and 0.3% Na₂HPO₄·12 H₂O (with orthogonal design data detailed in the supplementary data), The fermentation was initiated by inoculating the strain at 4% (v/v) into 250 mL shake flasks with a 60% liquid volume. Incubation was performed at 15 °C and 150 rpm for 48 h. After fermentation, the cells were pelleted by centrifugation at 4000 rpm for 30 min, and the supernatant was discarded. The cell pellet was resuspended in 10 mL of buffer (10 mM Tris-HCl, pH 7.0) and disrupted by sonication at 160 W for 10 min. The lysate was centrifuged at 13,500 rpm for 40 min, and the clarified supernatant was collected as the crude enzyme solution [36, 37]. Purification of Ph-HAase After subjecting the crude enzyme solution to static adsorption by mixing with Cellulose TM Sulfate affinity chromatography packing, the mixture was loaded onto the column, which was subsequently equilibrated with 10 mM Tris-HCl buffer (pH 7.0). Stepwise elution was then performed sequentially with 100 mL of 200 mM NaCl solution and 100 mL of 300 mM NaCl solution, followed by a final elution with 200 mL of 400 mM NaCl solution. The elution flow rate was maintained at 2 mL/min, and the eluate was automatically collected in fractions of 4–6 mL per tube [24, 38]. The fraction of Ph-HAase with high enzymatic activity purified via the Cellufine™ Sulfate column was collected. The obtained Ph-HAase was diluted 3–4-fold with ultrapure water, then loaded onto the UniGel-30CM ion-exchange chromatography column at a flow rate of 1 mL/min. Prior to loading, the column was equilibrated with 10 mM Tris-HCl buffer (pH 7.0), followed by step elution with 10 mM Tris-HCl buffer (pH 7.0) supplemented with 120 mM, 140 mM, and 160 mM NaCl respectively; 100 mL of eluent was collected for each elution condition at a flow rate of 1 mL/min. Eluted fractions were automatically collected by a fraction collector, with 4–6 mL of sample per tube [7, 39]. Following purification of the target enzyme via the aforementioned method, the enzyme fraction was collected and diluted 3 to 4-fold with ultrapure water. The diluted sample was subsequently reloaded at a flow rate of 1 mL/min onto a UniGel-30CM ion-exchange chromatography column that had been pre-equilibrated with 10 mM Tris-HCl buffer (pH 7.0). Next, linear gradient elution was carried out at 1 mL/min over a total elution volume of 300 mL, with the eluent system ranging from 10 mM Tris-HCl buffer (pH 7.0) to 500 mM Tris-HCl buffer (pH 7.0). The automatic fraction collector collected 4–6 mL of eluate per fraction [39]. Ph-HAase purity and homogeneity were assessed using 12% SDS-PAGE as described by Ebraheem [7]. The gel was operated at 30 volts for 10 min and then at 90 volts for 2 h. The molecular weight of the purified Ph-HAase was determined using a prestained protein ladder (15–250 kDa, BL Ultra) to compare its electrophoretic mobility after the gel was stained with Coomassie Brilliant Blue R250. Determination of Ph-HAase protein content by the BCA method Except for direct spectrophotometric methods (e.g., UV absorption at 280 nm), most protein quantification assays rely on chemical reactions to generate chromogenic products, which are then measured spectrophotometrically and compared with the color produced by standard proteins [7, 40]. Aliquots of diluted standard solutions (0, 1, 2, 4, 6, 8, 10, 15, and 20 µL) were pipetted into a 96-well plate, and the volume in each well was adjusted to 20 µL using the standard dilution buffer. Subsequently, 200 µL of the color development working solution was added to each well. After thorough mixing, the plate was covered and incubated at 37 °C for 30 min, then cooled to room temperature. The absorbance at 562 nm was measured using an ELISA microplate reader, and sample protein concentrations were calculated based on the standard curve [40]. Molecular weight of Ph-HAase by mass spectrometry The samples were fully dissolved with 50 µL of water and set aside. The samples were diluted to 1 µg/µL and centrifuged at 12,000 rpm for 10 min, and then analyzed. A U3000 UHPLC-Q Exactive high-resolution liquid-mass spectrometry system was used for data acquisition. Chromatographic separation: mobile phase A was an aqueous solution containing 0.1% formic acid; mobile phase B was an acetonitrile solution containing 0.1% formic acid. The liquid phase gradient was set as follows: 0–3 min, 2% B; 3–10 min, 2%-95% B; 10–13 min, 95% B; 13–13.1 min, 95%-2% B; 13.1–15 min, 2% B; and the flow rate was 0.3 mL/min. Chromatography column: ACQUITY UPLC Protein BEH C4, 300 Å, 1.7 μm, 2.1 × 50 mm, column temperature 70℃. Mass spectrometry acquisition: Sheath gas flow rate (45), Aux gas flow rate (10), Spray voltage (3.5 kV), Capillary temp. (320 °C), S-Lens RF Level (55), Aux gas heater temp. Scan Type (Full MS), Microscans (10), Resolution (17500), AGC target (3e6), Maximum IT (200 ms), Number of scan ranges (1), Scan range Spectrum (400–4000 m/z), Data type (Profile) [41]. Edman degradation of Ph-HAase N-terminal 10 amino acids To analyze the N-terminal region, the purified enzyme (20 µg) was loaded onto an SDS-PAGE gel (15% polyacrylamide). After electrophoresis, the gel was electrophoretically transferred onto a PVDF membrane cartridge. N-terminal amino acid sequence analysis was performed using an Applied Biosystems sequencer (ABI491A, PE Co.USA) [42]. Studies on the nature of Ph-HAase The optimal reaction pH and pH stability of Ph-HAase Substrate solutions were prepared using 5 mM Tris-HCl buffer at pH values of 5, 5.5, 6, 6.5, 7, 7.5, 8, 8.5, and 9, and the optimal reaction pH was determined at 25 °C. The relative enzyme activity at each pH was calculated, with the enzyme activity at pH 7 defined as 100% [8, 12, 17, 31, 33]. To evaluate the pH stability of Ph-HAase, the enzyme was incubated (at a volumetric ratio of 1:4 enzyme to buffer) in a 5 mM Tris-HCl buffer system adjusted to pH levels of 5.5, 6.5, 7.5, and 8.5. Following incubation periods of 2, 4, 8, 12, 18, and 24 h, enzyme activity was assayed at 25℃, with the initial enzymatic activity defined as 100% [7, 19, 24, 41, 43]. The optimal reaction temperature and thermal stability of Ph-HAase To identify the optimal reaction temperature for Ph-HAase, its enzymatic activity was evaluated across a temperature gradient spanning 25 °C to 75 °C with 5 °C increments (specifically 25 °C, 30 °C, 35 °C, 40 °C, 45 °C, 50 °C, 55 °C, 60 °C, 65 °C, 70 °C, and 75 °C) in 5 mM Tris-HCl buffer at pH 6.5. For comparative analysis, the enzymatic activity measured at 25 °C was normalized to 100% [8, 21, 26, 43, 45]. The effect of temperature on enzyme stability was evaluated by incubating Ph-HAase in a 5 mM Tris-HCl buffer (pH 6.5) at 30 °C, 35 °C, 40 °C, and 45 °C for durations ranging from 0 to 10 h, with measurements taken at hourly intervals. The initial activity at each temperature was defined as 100% [7, 19, 24, 41, 43]. Effect of different buffer solutions and different concentrations on Ph-HAase To determine the appropriate buffer and concentration for pH-Haase, we evaluated its enzymatic activity using sodium acetate, PBS, and Tris-HCl buffers at pH 6.5 with concentrations of 5, 25, 50, and 100 mM [7, 19, 24, 41, 43]. The initial enzyme activity was defined as 100%. Effect of metal To investigate the effects of metal ions on Ph-HAase, gradient concentrations of 10 mM, 25 mM, 50 mM, and 100 mM for the eight tested metal ion solutions (Mn²⁺, Mg²⁺, K⁺, Ca²⁺, Na⁺, Ba²⁺, Cu²⁺, Zn²⁺) were prepared with ultrapure water. Ph-HAase was incubated with each metal ion solution at room temperature (25 °C) for 30 min, followed by measurement of the residual enzyme activity, with the baseline activity of the enzyme before addition of metals defined as 100% [19, 24, 41, 43]. Substrate specificity The substrate specificity of Ph-HAase was determined by assaying its catalytic activity against a panel of substrates, including HA derived from Streptococcus, chondroitin sulfate A (CS-A), dermatan sulfate A (DS-A), heparin, inulin, gum arabica, galactose, sodium carboxymethyl cellulose (CMC-Na), dextran, sodium D-alginate, and κ-carrageenan. All substrates, with the exception of HA, were purchased from Aladdin Biochemical Technology Co., Ltd. (Shanghai, China). Each substrate was prepared in 5 mM Tris-HCl buffer (pH 7.0) to a final concentration of 1 mg/mL. Ph-HAase was incubated with each substrate solution at 25 °C (room temperature) for 10 min, followed by the determination of enzymatic activity for each substrate [41, 43]. The enzymatic activity toward HA was defined as 100%. The cytotoxicity of the Ph-HAase on normal and cancer cell lines using the MTT assay SK-OV-3, HepG2, A549, MCF-7, B16F10 and HaCaT cells were purchased from the Shanghai Cell Bank, Chinese Academy of Sciences. MCF-7 and B16F10 cells were cultured in RPMI-1640 Medium containing 10% fetal bovine serum (FBS), 100 U/mL penicillin and 100 µg/mL streptomycin at 37℃ in a 5% CO2 incubator, while the remaining cells were cultured in Dulbecco’s Modified Eagle Medium (DMEM) under the same conditions [44]. All cells were used for experiments after being passaged to the third generation. SK-OV-3 cells (1 × 104 cells/well), HepG2 cells (8 × 103 cells/well), A549 cells (1 × 104 cells/well), MCF-7 cells (1.5 × 104 cells/well), B16F10 cells (5 × 103 cells/well) and HaCaT cells (1.5 × 104 cells/well) were seeded into 96-well plates for 24 h adherence (40%-50% confluence), followed by treatment with Ph-HAase (0, 10, 20, 30, 40, 50, 60, 70, 80, and 90 µg/mL) for 24 h. Then, MTT solution (5 mg/mL) was added to each well and incubated at 37 °C for 4 h MTT solution was discarded, and 200 µL of dimethyl sulfoxide (DMSO) was added to each well [7, 44]. Optical density (OD) was measured at 490 nm using a microplate reader. Cell viability (%)=(treated OD/control OD)×100%. Dose-response data were analyzed via nonlinear regression modeling using GraphPad Prism 10.0 (GraphPad Software, USA) to calculate the half-maximal inhibitory concentration (IC₅₀). Curve fitting was performed with the “log (inhibitor) vs. response—variable slope (four parameters)” model. The goodness of fit for each fitted curve was assessed using the coefficient of determination (R²), and all R² values exceeded 0.95 [44]. It was found that Ph-HAase could effectively inhibit B16F10 cells. Ph-HAase concentrations of 20, 30, and 40 µg/mL were used to treat B16F10 cells for 24 h. Then, we observed cell morphology using a phase-contrast microscope (Olympus, Germany). Effects of Ph-HAase on mitochondrial membrane potential, reactive oxygen species (ROS), and apoptosis in B16F10 cells Since Ph-HAase selectively inhibited B16F10 cells, 2 × 105 cells per well were seeded into a 6-well plate and incubated for 24 h. Subsequently, the cells were treated with Ph-HAase at concentrations of 20, 30, and 40 µg/mL for 12 h. After harvesting, the cells were stained with Hoechst 33,342, DCFH-DA, and JC-1 probes respectively, and incubated at 37 °C in the dark for 20–30 min. After incubation, the cells were washed three times with PBS to remove unbound excess dye, resuspended in 1 mL of serum-free medium, and analyzed via fluorescence microscopy and flow cytometry. Imaging observation was performed using an inverted fluorescence microscope. Hoechst 33,342 was used to characterize apoptotic nuclear morphology; the excitation (Ex) and emission (Em) wavelengths were set to 350 nm and 460 nm respectively, with a DAPI filter cube adopted. DCFH-DA was applied to quantify intracellular reactive oxygen species (ROS) levels, with Ex/Em configured to 488/525 nm via an FITC filter set. JC-1 was employed to assess mitochondrial membrane potential: with excitation at 488 nm, dual-channel fluorescence signals were acquired at 525 nm (green fluorescence corresponding to JC-1 monomers) and 590 nm (red fluorescence corresponding to JC-1 aggregates) [45, 46]. Flow cytometry analysis was performed with a flow cytometer. DCFH-DA-stained samples were excited with a 488 nm argon-ion laser, and fluorescence signals were collected through a 530/30 nm bandpass filter. For JC-1-stained samples, excitation was also performed at 488 nm, with emission signals detected via 530/30 nm (JC-1 monomers) and 585/42 nm (JC-1 aggregates) bandpass filters. For JC-1 and Annexin V-PE dual-stained samples, fluorescence compensation was performed using single-stained controls (JC-1 only and Annexin V-PE only) prior to flow cytometric data acquisition to minimize spectral overlap interference. The compensation matrix was established with FL-2 – FL-1 = 15.2%. Post-acquisition compensation matrix correction was conducted using FlowJo software. Apoptosis was detected via the Annexin V-FITC/PI double staining assay: the FITC signal was excited at 488 nm and collected through a 530/30 nm filter, while the PI signal was detected with a 585/42 nm filter [45, 46]. Quantitative analysis of gene expression changes in B16F16 cells Total RNA was extracted from B16F10 cells treated with Ph-HAase (20, 30, and 40 µg/mL) and untreated B16F10 cells using the Gene JET RNA Purification Kit (Thermo Scientific, USA). Complementary DNA (cDNA) was synthesized from RNA using the HiScript RT Super Mix, followed by quantification of Caspase-3, Caspase-9, Bcl-2, Bax, and Ki-67 expression levels via the MyiQ2 Real-Time PCR Detection System (Bio-Rad USA) [7]. For specific experimental details, please refer to the Supplementary data. Detection of apoptosis-related proteins in B16F10 cells using an ELISA kit The levels of tumor marker proteins (Caspase-3 and Caspase-9), anti-apoptotic proteins (Bcl-2), and pro-apoptotic proteins (Bax) in the mitochondrial apoptotic pathway, as well as the cell proliferation protein Ki-67, were all determined using ELISA kits (Sino Gene Clon Biotech Co., Hangzhou, China) and ELISA microplate readers (Dynatech Microplate Reader Model MR 5000). Mouse breeding and model establishment All animal experiments were conducted in accordance with protocols approved by the Animal Ethics Committee of Guilin Medical University (Approval No. GLMU-IACUC-202510110). Female C57BL mice aged 6 to 8 weeks (License No.: SCXK(Yu)2020-0005) were purchased from Henan Skobes Biotechnology Co., Ltd. The mice were raised under specific pathogen-free conditions at 20–24 °C, 55 ± 10% relative humidity, and a 12-hour light/dark cycle, with food and water provided ad libitum after a one-week quarantine and acclimation period. Forty C57BL mice were subcutaneously injected with a mouse melanoma B16F10 cell suspension, and palpable solid tumors formed on their backs after 15 days. The mice were then divided into four groups of 10 each: the model group received daily intratumoral injections of 50 µL normal saline, the positive control group was given 50 µL 5-fluorouracil (5-FU, 20 mg/kg) daily, the low-dose treatment group received 50 µL Ph-HAase (10 mg/kg) daily, and the high-dose treatment group was administered 50 µL Ph-HAase (20 mg/kg) daily. After 15 consecutive days of treatment, mice were sacrificed by cervical dislocation, and the tumors of each group were collected, photographed, weighed, and analyzed [47, 48]. Histological analysis The resected tumor lesions were fixed in 10% neutral buffered formalin for 48 h prior to histopathological evaluation. Following fixation, the specimens were subjected to gradient rinsing, graded dehydration, and paraffin embedding. Serial sections with a thickness of approximately 7 μm were subsequently prepared, stained with hematoxylin and eosin (H&E) for histopathological observation, and imaged via optical microscopy to characterize the morphology of the stained tissue Sections [48]. Statistical analyses All the data are presented as the mean ± standard deviation (SD) of three independent experiments. Two-tailed Student’s t test and one-way analysis of variance (ANOVA) followed by Tukey’s post-hoc test for multiple comparisons were used for group comparisons using GraphPad Prism 10.0 (GraphPad Software, San Diego, CA, USA). Variance homogeneity was checked using Levene’s test before applying ANOVA. A P value < 0.05 was considered statistically significant. Result and discussion Fermentation optimization of Ph-HAase This study investigates the optimal production conditions of Ph-HAase from P. heparinus by regulating the components of the fermentation medium (including carbon source, nitrogen source, phosphorus source) and key fermentation parameters (including temperature, inoculum size, medium volume, initial pH). The production of HAase by fermentation strains is influenced by various factors, including the composition of the culture medium (nitrogen, phosphorus, and carbon sources) and fermentation conditions (pH, temperature, time, and inoculation volume) [36, 37]. Microorganisms can sense the environment and conduct signal transduction, converting specific substrates (or their degradation products) into transcriptional signals, thereby initiating the synthesis of corresponding degradation enzyme systems [49]. Streptomyces graminisoli, an actinomycete isolated from soil, can produce HAase during its growth when HA is used as the sole carbon and nitrogen source in the culture medium, which differs from the previously focused HA-induced regulatory mechanism (i.e., HA serving as a specific signal molecule to activate gene transcription) for bacterial HAase synthesis [50]. In our results (Fig. 1A), the addition of HA to the P. heparinus fermentation broth induced HAase production. This result supports previous findings. In Fig. 1B, cell growth and Ph-HAase production increased concomitantly with rising tryptone concentration. At low tryptone levels, prolonged fermentation led to nutrient depletion, which impaired normal bacterial growth and metabolism [51]. As illustrated in Fig. 1C, enzyme activity reached 3.25 IU/mL at a Na₂HPO₄·12 H₂O concentration of 0.3%. Similarly, as shown in Fig. 1D, a CaCl₂ concentration of 0.05% yielded a peak enzyme activity of 3.37 IU/mL. Chang et al. [52] discovered that during the production of transglutaminase, adding an appropriate amount of inorganic salts could promote the enzyme production of the Streptomyces mobaraensis. Figure 1E demonstrates that Ph-HAase activity remained largely stable within an initial pH range of 7.5-8.0, indicating that the strain exhibited stable enzyme production ability under neutral and slightly alkaline conditions. Sahoo et al. [36] noted that the pH of the culture medium is a key factor affecting the production of metabolic substrates, as it not only regulates the nature of the culture medium and the solubility of substances, but also determines the ionic state of HA, a bacterial substrate. At the same time, the studies by Patil et al. [41] and Kadhum [53] also indicated that a neutral pH is most conducive to the production of HAase, and this result is consistent with our research findings. The highest Ph-HAase yield was achieved at an inoculum size of 4% (Fig. 1F). Studies have shown that the optimal inoculum size, typically 4% to 10%, can achieve the maximum enzyme production. However, amounts exceeding 10% may inhibit bacterial growth and enzyme synthesis by prematurely depleting nutrients [36]. As shown in Fig. 1G, enzyme production was optimal at loading volumes between 50% and 60%. Lower volumes increased the headspace and dissolved oxygen, promoting growth; however, excessively low volumes risked nutrient insufficiency in later stages, thereby affecting normal metabolism [36, 54]. Figure 1 H shows that enzyme activity peaked after 48 h of fermentation and declined gradually thereafter, likely due to nutrient depletion from prolonged fermentation [36, 54]. The optimal temperature for enzyme production varies among different strains. A temperature of 30 °C was found optimal for the fermentation of leech HAase using Pichia pastoris [55]. As seen in Fig. 1I, the highest enzyme activity was observed at 15 °C and decreased with increasing temperature, confirming that the optimal Ph-HAase production for this strain occurs at 15 °C. Fig. 1 Fermentation optimisation for HAase production by P. heparinus. (A) Inducer; (B) Tryptone; (C) Disodium hydrogen phosphate dodecahydrate; (D) Calcium chloride; (E) pH; (F) Inoculum dose; (G) Liquid volume; (H) Time; (I) Temperature Fermentation optimisation for HAase production by P. heparinus. (A) Inducer; (B) Tryptone; (C) Disodium hydrogen phosphate dodecahydrate; (D) Calcium chloride; (E) pH; (F) Inoculum dose; (G) Liquid volume; (H) Time; (I) Temperature Purification of Ph-HAase In previous studies, HAase purification was performed using DEAE-cellulose ion-exchange chromatography and Sephadex G-100 gel filtration [7, 41, 50]. Similarly, in this study, the initial specific activity of Ph-HAase in the crude extract was 0.68 IU/mg. After affinity chromatography with Cellufine ™ Sulfate, the specific activity increased to 6.62 IU/mg. Purification was further performed using a UniGel-30CM ion-exchange chromatography column with a NaCl gradient elution method. The specific activity reached 16.37 IU/mg, resulting in a purification fold of 24.1 and a recovery yield of 50.6%. After the second purification, Ph-HAase was further subjected to UniGel-30CM chromatography and eluted with a linear gradient of Tris-HCl (10–500 mM). Finally, the obtained Ph-HAase had a specific activity of 32.32 IU/mg, with a purification fold of 47.5 and a recovery yield of 43.1% (Fig. 2; Table 1). Fig. 2Ph-HAase elution profiles. (A) Cellufine TM Sulfate Affinity chromatography elution; (B) UniGel-30CM NaCl Ion exchange chromatography gradient elution; (C) UniGel-30CM Tris-HCl Ion exchange chromatography linear elution; (D) SDS-PAGE gel electrophoresis; (D1) Ph-HAase crude enzyme; (D2) Cellufine TM Sulfate elution; (D3) UniGel-30CM NaCl gradient elution; (D4) UniGel-30CM Tris-HCl linear elution Ph-HAase elution profiles. (A) Cellufine TM Sulfate Affinity chromatography elution; (B) UniGel-30CM NaCl Ion exchange chromatography gradient elution; (C) UniGel-30CM Tris-HCl Ion exchange chromatography linear elution; (D) SDS-PAGE gel electrophoresis; (D1) Ph-HAase crude enzyme; (D2) Cellufine TM Sulfate elution; (D3) UniGel-30CM NaCl gradient elution; (D4) UniGel-30CM Tris-HCl linear elution Table 1Summary of purification of Ph-HAase enzyme by P. heparinusPurification stepTotal protein (mg)Total activity (IU)Specific activity (IU/mg)Purification foldYield (%)Crude enzyme243316500.681100Cellufine TM Sulfate18011926.629.772.2UniGel-30CM(NaCl)5183516.3724.150.6UniGel-30CM (Tris-HCl)2271132.3247.543.1 Table 1Summary of purification of Ph-HAase enzyme by P. heparinusPurification stepTotal protein (mg)Total activity (IU)Specific activity (IU/mg)Purification foldYield (%)Crude enzyme243316500.681100Cellufine TM Sulfate18011926.629.772.2UniGel-30CM(NaCl)5183516.3724.150.6UniGel-30CM (Tris-HCl)2271132.3247.543.1 Summary of purification of Ph-HAase enzyme by P. heparinus UniGel-30CM (NaCl) Molecular weight by LC-MS Three components of Ph-HAase were resolved by reversed-phase ultra-high performance liquid chromatography (UHPLC) coupled with high-resolution mass spectrometry (LC-MS/MS). A Waters ACQUITY UPLC Protein BEH C4 column (300 Å, 1.7 μm, 2.1 × 50 mm) was used at 70 °C, with a gradient elution of 0.1% formic acid in water (mobile phase A) and 0.1% formic acid in acetonitrile (mobile phase B). Mass spectra were acquired on a Q Exactive hybrid quadrupole-Orbitrap mass spectrometer in full‑scan mode (m/z 400–4000) at a resolution of 17,500. The raw data were deconvoluted using BioPharma Finder software, obtain the corresponding molecular weight (Fig. 3A). The most abundant protein species of the three components exhibited molecular masses of 16,807.33 Da, 28,060.91 Da, and 79,616.96 Da, respectively (Fig. 3B). The 79 kDa component was confirmed as the target protein Ph-HAase by mass matching. Quantitative analysis based on the integrated peak areas of the total ion current chromatogram (TIC) revealed that the 79 kDa component accounted for approximately 49% of the total protein signal, whereas the 16 kDa and 28 kDa components represented about 31% and 20%, respectively (supplementary data). These data demonstrate that the target protein is the dominant species, while the remaining components are non‑target impurities at substantially lower abundance. The raw and deconvoluted mass spectra for all three components are provided in the supplementary data. Furthermore, the molecular weights of the HAase purified from microorganisms have been reported as follows: B. intermedia (65 kDa), Arthrobacter globiformis (73.7 kDa), Brevibacterium halotolerans (43 kDa), S. graminisoli (35 kDa), Streptococcus dysgalactiae (125 kDa), Paenibacillus yunnanensis (74 kDa) and Paennarthrobacter nicotinovorans (70 kDa) [7, 24, 36, 41, 50, 56]. Fig. 3LC-MS of Ph-HAase molecular weight. (A) TIC profile of the enzyme sample, (B) Molecular mass of the enzyme based on mass spectrometry analysis LC-MS of Ph-HAase molecular weight. (A) TIC profile of the enzyme sample, (B) Molecular mass of the enzyme based on mass spectrometry analysis N-terminal amino acid sequencing No N-terminal amino acid sequence was detected in the purified Ph-HAase. We hypothesize that this phenomenon may be attributed to N-terminal blocking: the blocking may result from acetylation or methylation modifications, or spontaneous cyclization that induces pyroglutamate formation, both of which inhibit the Edman degradation reaction. Previous studies have demonstrated that heparanase isolated from the same strain of P. heparinus also failed to yield a detectable amino acid sequence via Edman degradation [57]. The chromatogram obtained from the N-terminal sequencing analysis of Ph-HAase is presented in the supplementary data. Gu et al. [57] purified chondroitin AC lyase, glycuronidase, and chondroitin B lyase from P. heparinus; these enzymes also lacked N-terminal sequences. However, it is noteworthy that the molecular weights of these enzymes were determined to be 74, 41.8, and 55.2 kDa, respectively [57]. This is significantly different from the 79.6 kDa Ph-HAase we had previously identified. Therefore, we hypothesize that Ph-HAase may be a novel HAase. Furthermore, the molecular weights of chondroitin B from Huang W and Michel G were 57.4 kDa and 53.6 kDa, respectively [58, 59]. Studies on the nature of Ph-HAase After successfully purifying Ph-HAase, we conducted studies on its enzymatic properties. As illustrated in Fig. 4A, the enzyme exhibited maximum activity at pH 6.5 in Tris-HCl buffer. When assayed across a temperature range of 25–75 °C, Ph-HAase reached peak activity at 45 °C, beyond which a decline was observed (Fig. 4B). Consistent with the results of Guo et al. [35], the optimal reaction temperature and pH for the HAase from Bacillus were 44 °C and 6.5, respectively. As shown in Fig. 4C and D, the enzyme demonstrated optimal stability at pH 7.5 and 30 °C. These results are consistent with those of Ebraheem & Patil [7, 24], who found that HAase activity remains stable below 40℃, beyond 40℃, the activity significantly decreases [60]. Zhu & Li [24, 41] reported that HAase exhibited stability at pH 5–7, which is similar to the pH of the human body. Regarding buffer effects, enzyme activity was highest in sodium acetate and Tris-HCl buffers at a concentration of 5 mM (pH 6.5). In contrast, PBS buffer strongly suppressed activity in a concentration-dependent manner (Fig. 4E). The research conducted by Zhang et al. [61] revealed that HAase exhibited the highest activity in the NaH2PO4-Na2HPO4 buffer solution (with a pH of 7.0). As shown in Fig. 4F, Cu2+ and Zn2+ can inhibit the activity of Ph-HAase, among which Cu2+ has the strongest inhibitory effect. In contrast, low Ca2+ concentrations can enhance the activity of Ph-HAase. This result is consistent with the findings of Zhu et al. [24]. who discovered that the presence of Ca2+ and Mg2+ enhanced HAase activity, while Zn2+ and Cu2+ severely inhibited it. Fig. 4Effect of temperature, pH, buffers, and metal on Ph-HAase activity and stability. (A) The optimal reaction pH of Ph-HAase at 25 °C; (B) Optimal Reaction Temperature of Ph-HAase in 5 mM Tris-HCl Buffer (pH 6.5); (C) The influence of varying pH levels (prepared in 5 mM Tris-HCl buffer at 25 °C) on the stability of Ph-HAase; (D) Thermal stability of Ph-HAase in 5 mM Tris-HCl (pH 6.5) buffer solution; (E) The impact of three buffer solutions at varying concentrations (pH 6.5) on Ph-HAase activity; (F) Effects of different concentrations of metal on Ph-HAase Effect of temperature, pH, buffers, and metal on Ph-HAase activity and stability. (A) The optimal reaction pH of Ph-HAase at 25 °C; (B) Optimal Reaction Temperature of Ph-HAase in 5 mM Tris-HCl Buffer (pH 6.5); (C) The influence of varying pH levels (prepared in 5 mM Tris-HCl buffer at 25 °C) on the stability of Ph-HAase; (D) Thermal stability of Ph-HAase in 5 mM Tris-HCl (pH 6.5) buffer solution; (E) The impact of three buffer solutions at varying concentrations (pH 6.5) on Ph-HAase activity; (F) Effects of different concentrations of metal on Ph-HAase Substrate specificity Research indicates that the HAase derived from A. globiformis not only degrades HA but also has the ability to degrade chondroitin sulfate (CS) [24]. As shown in Table 2, Ph-HAase exhibited the highest specificity for HA. Significant activity was also observed toward CS-A (58% relative to HA) and DS-A (30%). Table 2Substrate specificity of Ph-HAaseSubstrateRelative activity (%)HA (MW20-40 kDa)100CS-A58DS-A30Heparin (Animal tissue)2Inulin (Jerusalem artichoke)1Gum arabica1CMC-Na0Dextran (Microbial fermentation)0Trehalose (Botanical starch)0κ-carrageenan0 Table 2Substrate specificity of Ph-HAaseSubstrateRelative activity (%)HA (MW20-40 kDa)100CS-A58DS-A30Heparin (Animal tissue)2Inulin (Jerusalem artichoke)1Gum arabica1CMC-Na0Dextran (Microbial fermentation)0Trehalose (Botanical starch)0κ-carrageenan0 Substrate specificity of Ph-HAase Effects of Ph-HAase on Melanoma B16F10 cells Studies have shown that HAase can inhibit the activity of various cancer cells, while having very little cytotoxicity towards normal human cells [7]. This is attributed to differences in HA expression levels between tumor and normal cells [7]. The high accumulation of HA in the ECM of melanoma is closely related to its high invasiveness and metastatic potential, making it a potential target for HAase-mediated anti-tumor therapy [62]. The MTT assay results demonstrate that Ph-HAase exerts a selective inhibitory effect on B16F10 cells. Concurrently, a high concentration of Ph-HAase also exhibits inhibitory activity against HaCaT cells, while showing no significant impact on other tumor cell lines (Fig. 5A). The IC₅₀ of Ph-HAase was determined to be 28.63 µg/mL for B16F10 cells and 86.12 µg/mL for HaCaT cells (Fig. 5B). Observation under an inverted microscope revealed that untreated B16F10 cells exhibited a high cell density, well-spread morphology, and a uniform, transparent cytoplasm (Fig. 5C). In contrast, after 24 h of Ph-HAase treatment, the cells showed marked morphological changes, including contraction, rounding, reduced size, and poor substrate adhesion. With increasing concentrations of Ph-HAase, these effects were further exacerbated, leading to extensive cell rounding, detachment, membrane rupture, and apparent necrotic alterations. Fig. 5Effects of Ph-HAase on various cancer cells and normal cells. (A) Viability of normal and cancer cells after Ph-HAase treatment; (B) IC50 of Ph-HAase on normal and cancer cells; (C) Morphology of B16F10 cells treated with different concentrations of Ph-HAase Effects of Ph-HAase on various cancer cells and normal cells. (A) Viability of normal and cancer cells after Ph-HAase treatment; (B) IC50 of Ph-HAase on normal and cancer cells; (C) Morphology of B16F10 cells treated with different concentrations of Ph-HAase Effect of Ph-HAase on mitochondrial ROS and membrane potential changes in B16F10 cells Previous studies have established mitochondrial dysfunction as a well-established trigger of apoptosis, characterized by structural alterations, loss of membrane potential, and disruption of electron transport, thereby leading to ROS accumulation and activation of apoptotic pathways [63]. Changes in intracellular reactive oxygen ROS were detected by flow cytometry using the DCFH-DA fluorescent probe method [64]. DCFH-DA reacts with ROS to form highly fluorescent DCF, the fluorescence intensity of which (typically at excitation/emission wavelengths of 488 nm/525 nm) is directly proportional to the intracellular ROS level, thereby enabling quantitative analysis of ROS content [64, 65]. The results (Fig. 6) show that after treatment with different concentrations of Ph-HAase for 24 h, the intracellular ROS content of B16F10 cells increased with increasing Ph-HAase concentration. The flow cytometry results also confirmed this conclusion. When Ph-HAase was applied to B16F10 cells, it increased intracellular ROS levels. The primary action of Ph-HAase is the enzymatic degradation of HA, a key glycosaminoglycan in the tumor ECM. This is consistent with the results reported by Lokeshwar et al. [14], who found that HAase degradation of HA leads to oxidative stress in tumor cells and mitochondrial dysfunction [66]. The primary receptor of HA is CD44, when HA binds to CD44, it can activate downstream pathways such as PI3K/Akt, promoting cell proliferation, invasion, and chemotherapy resistance [67, 68]. The degradation of HA by PH-HAase is likely to eliminate these CD44-mediated survival signals. Notably, the interaction between HA and CD44 is a dynamic factor in regulating intracellular redox balance [14]. Research has demonstrated that disrupting this axis leads to excessive ROS, which damages mitochondrial antioxidant defenses and causes oxidative stress [63]. This oxidative stress, in turn, induces the persistent opening of the permeability transition pore (mPTP), leading to an irreversible loss of membrane potential [63]. At this point, mitochondria themselves release more ROS, forming a vicious cycle of “ROS-induced ROS release” [69]. To determine whether apoptosis is mediated through the mitochondrial pathway, JC-1 (5,5′,6,6′-tetrachloro-1,1′,3,3′-tetraethylbenzimidazolylcarbocyanine iodide), a fluorescent probe, was employed to evaluate mitochondrial membrane potential. JC-1 is a membrane potential-sensitive probe that accumulates as aggregates in the mitochondrial matrix under high membrane potential conditions, emitting red fluorescence (excitation/emission wavelength: approximately 488 nm/590 nm). Upon depolarization of the membrane potential, JC-1 disperses into the cytoplasm in its monomeric form, resulting in green fluorescence (excitation/emission wavelength: approximately 488 nm/525 nm). Consequently, the red-to-green fluorescence intensity ratio serves as a quantitative indicator of mitochondrial membrane potential levels. As illustrated in Fig. 7A, in the blank control group, JC-1 predominantly exists in aggregated form, exhibiting intense red fluorescence. In the positive control group treated with the mitochondrial oxidative phosphorylation uncoupler carbonyl cyanide m-chlorophenyl hydrazone (CCCP), membrane potential collapsed, leading to the complete conversion of JC-1 into monomers and a dominance of green fluorescence. Following treatment with Ph-HAase (20, 30, 40 µg/mL), the red fluorescence intensity in B16F10 cells decreased progressively with increasing concentrations, while green fluorescence intensified markedly, suggesting a concentration-dependent decline in mitochondrial membrane potential. To quantify mitochondrial membrane potential alterations, flow cytometric analysis was performed. As illustrated in Fig. 7B, a two-parameter scatter plot was generated using FL-1 (525 nm, detecting JC-1 monomers, green fluorescence) and FL-2 (585 nm, detecting JC-1 aggregates, red fluorescence). In the control group, the majority of cells were localized in the Q2 quadrant (high red/low green fluorescence), indicating a high level of membrane potential. Conversely, cells treated with CCCP (positive control) predominantly accumulated in the Q3 quadrant (high green/low red fluorescence), confirming complete membrane potential depolarization. Following treatment with Ph-HAase at concentrations of 20, 30, and 40 µg/mL, a concentration-dependent shift of the cell population from Q2 to Q3 was observed. Moreover, the proportion of cells in the Q3 quadrant exhibited a progressive increase with escalating concentrations. Zhao et al. [70] demonstrated that elevating intracellular ROS levels and reducing mitochondrial membrane potential in B16F10 cells induces cell necrosis, while Gao et al. [71] reported that the natural compound Jolkinolide B increases ROS production in B16F10 cells in a concentration-dependent manner and thus induces mitochondrial damage. Fig. 6Effect of Ph-HAase on B16F10 intracellular reactive oxygen species levels. (A) Fluorescence staining graph of B16F10 reactive oxygen species levels; (B) Flow cytometry of B16F10 reactive oxygen species levels Effect of Ph-HAase on B16F10 intracellular reactive oxygen species levels. (A) Fluorescence staining graph of B16F10 reactive oxygen species levels; (B) Flow cytometry of B16F10 reactive oxygen species levels Fig. 7Effect of Ph-HAase on mitochondrial membrane potential levels in B16F10 cells. (A) Fluorescence staining graph of B16F10 cell membrane potential level; (B) Flow cytometry of B16F10 cell membrane potential level Effect of Ph-HAase on mitochondrial membrane potential levels in B16F10 cells. (A) Fluorescence staining graph of B16F10 cell membrane potential level; (B) Flow cytometry of B16F10 cell membrane potential level Effect of Ph-HAase on apoptosis in B16F10 cells Hoechst 33,342 staining was employed to assess nuclear morphological changes associated with apoptosis. As shown in Fig. 8A, untreated control cells exhibited uniform, faint blue nuclear staining with intact round or oval nuclei. Following treatment with Ph-HAase (20, 30, and 40 µg/mL) for 24 h, B16F10 cells displayed progressively denser nuclear staining, nuclear fragmentation, and chromatin condensation in a concentration-dependent manner, characteristic of apoptotic cell death. To quantitatively discriminate between early and late apoptotic populations, Annexin V-FITC/PI double staining was performed and analyzed by flow cytometry. Q1 quadrant (Annexin V⁻/PI⁺) represents necrotic or mechanically damaged cells. Q2 quadrant (Annexin V⁺/PI⁺) represents late apoptotic or necrotic cells, with both phosphatidylserine exposure and membrane permeabilization. Q3 quadrant (Annexin V⁺/PI⁻) represents early apoptotic cells, with exposed phosphatidylserine but intact plasma membrane. Q4 quadrant (Annexin V⁻/PI⁻) represents viable cells [72, 73]. As shown in Fig. 8B, in the control group, the majority of cells resided in the Q4 quadrant (viable cells, 83.45%), with only minimal early apoptotic (Q3, 1.27%) and late apoptotic (Q2, 7.09%) populations. Following treatment with increasing concentrations of Ph-HAase (20, 30, and 40 µg/mL), a progressive increase in apoptotic populations was observed. Notably, the late apoptotic population (Q2) increased from 7.09% (control) to 11.52%, 15.34%, and 27.92% at 20, 30, and 40 µg/mL, respectively, while the early apoptotic population (Q3) remained relatively low (1.27%, 1.37%, 1.66%, and 2.86%, respectively). These results indicate that Ph-HAase induces apoptosis in B16F10 cells in a concentration-dependent manner, with the effect predominantly attributed to late apoptosis. This finding is consistent with the nuclear fragmentation observed by Hoechst staining (Fig. 8A). As shown in Fig. 9, oxidative stress and mitochondrial dysfunction increased the expression of Caspase9 and Caspase3 in B16F10 cells, further confirming that the apoptosis induced by Ph-HAase in B16F10 cells is mediated through the intrinsic pathway of mitochondria. The Bcl-2 protein family plays a key role in regulating mitochondrial membrane permeability and intrinsic apoptosis, and the dynamic balance between its anti-apoptotic protein Bcl-2 and pro-apoptotic proteins such as Bax controls cell survival and death [74]. In our study, the significant upregulation of Bax and the downregulation of Bcl-2 indicated that this balance was disrupted, promoting the progression of B16F10 cell apoptosis. Consistent with the findings of Sun et al. [13], ECM remodeling mediated by HAase can regulate the expression of Bcl-2 family proteins and induce tumor cell apoptosis. The significant downregulation of Ki67 (a cell proliferation marker) indicates that Ph-HAase not only induces B16F10 cell apoptosis but also inhibits cell proliferation, demonstrating a dual anti-tumor effect and suggesting its potential in anti-melanoma therapy. It suggests that Ph-HAase may exert its anti-melanoma effect by simultaneously regulating the apoptotic and proliferative pathways. These molecular changes (upregulation of Caspase9, Caspase3, Bax; downregulation of Ki67, Bcl-2) confirmed that Ph-HAase exerts its anti-melanoma effect by activating the intrinsic apoptotic pathway and inhibiting cell proliferation, consistent with previous findings of ROS accumulation and mitochondrial membrane potential collapse. Fig. 8Effect of Ph-HAase on apoptosis of B16F10 cells. (A) Fluorescence staining graph of the apoptosis level of B16F10 cells; (B) Flow cytometry of the apoptosis level of B16F10 cells Effect of Ph-HAase on apoptosis of B16F10 cells. (A) Fluorescence staining graph of the apoptosis level of B16F10 cells; (B) Flow cytometry of the apoptosis level of B16F10 cells Fig. 9(A) Through real-time quantitative PCR, the changes in the expression of Caspase 3, Caspase-9, Bax, Bcl-2, and Ki-67 genes in B16F10 cells after 24 h of Ph-HAase treatment were determined compared to the untreated cells. (B) Using ELISA, the changes in the expression of Caspase 3, Caspase-9, Bax, Bcl-2, and Ki-67 proteins in B16F10 cells after 24 h of Ph-HAase treatment were determined relative to untreated cells. Compared with the blank control group, *P < 0.05, **P < 0.01,***P < 0.001 (A) Through real-time quantitative PCR, the changes in the expression of Caspase 3, Caspase-9, Bax, Bcl-2, and Ki-67 genes in B16F10 cells after 24 h of Ph-HAase treatment were determined compared to the untreated cells. (B) Using ELISA, the changes in the expression of Caspase 3, Caspase-9, Bax, Bcl-2, and Ki-67 proteins in B16F10 cells after 24 h of Ph-HAase treatment were determined relative to untreated cells. Compared with the blank control group, *P < 0.05, **P < 0.01,***P < 0.001 Effect of Ph-HAase in a mouse model of melanoma To evaluate the effect of subcutaneous injection of Ph-HAase on tumor progression, male C57BL mice were subcutaneously inoculated with B16F10 cells. On the 7th day, subcutaneous tumors were clearly visible, and by day 15, the tumor area reached approximately 1 cm². The tumor-bearing mice were then randomly divided into four groups: the positive control group received an intratumoral injection of 5-FU. The model group received an intratumoral injection of PBS. The remaining two groups were the Ph-HAase treatment groups. The positive control drug 5-FU (30 mg/kg) has been verified as an effective dosage for intraperitoneal injection in the B16F10/C57BL melanoma model [75]. For intratumoral injection, we adjusted the dosage to 20 mg/kg. The doses for the Ph-HAase treatment group (10 and 20 mg/kg) are the set exploratory doses, aiming to preliminarily compare the effects of Ph-HAase with those of the classic anticancer drug 5-FU at the same dose. After 15 days of treatment, mice were sacrificed by cervical dislocation, and tumors were dissected and weighed (Fig. 10). Compared with the model group, both the Ph-HAase treatment groups and the positive control group showed a significant reduction in tumor volume. Moreover, tumor growth inhibition was more pronounced in the Ph-HAase-treated groups than in the positive control group. Additionally, the model group showed a more pronounced decrease in body weight than the other three groups. These results demonstrate the potential of Ph-HAase to suppress melanoma growth and confirm its antitumor efficacy following administration. Wang et al. [12] engineered the HAase gene into oncolytic poxviruses, enabling the viruses to secrete HAase in situ, degrade HA in the tumor cell extracellular matrix, and, consequently, reshape the tumor microenvironment. As a result of this remodeling effect, the anti-tumor efficacy of chemotherapy drugs in the B16-F10 melanoma mouse model was significantly enhanced [12]. Hanouna et al. [76] found that treating B16-F10 melanoma mice with probenecid, to reduce calpain exocytosis, significantly inhibited tumor growth and reduced the final tumor volume to approximately one-third that of the control group. Unfortunately, the current study did not detect any systemic toxicity indicators, a crucial step that must be completed in our subsequent experiments. This includes blood collection after treatment and performing complete blood cell counts and serum biochemical analyses (such as ALT, AST, creatinine, etc.) to comprehensively evaluate the safety profile of Ph-HAase. Fig. 10Effect of Ph-HAase on melanoma in mice. (A) Changes in body weight of mice during the 30-Day period from model establishment to drug administration. (B) Resected tumors after treatment. (C) changes in the tumor volume of mice from the time of model establishment to 30 days after drug administration. (D) Comparison of tumor mass among the four groups. Compared with the blank control group, *P < 0.05, **P < 0.01 Effect of Ph-HAase on melanoma in mice. (A) Changes in body weight of mice during the 30-Day period from model establishment to drug administration. (B) Resected tumors after treatment. (C) changes in the tumor volume of mice from the time of model establishment to 30 days after drug administration. (D) Comparison of tumor mass among the four groups. Compared with the blank control group, *P < 0.05, **P < 0.01 Histopathology of melanoma in a mouse model HE staining revealed densely packed and uniformly arranged tumor cells with deeply stained nuclei in the model group. In contrast, necrotic tumor cells were observed in both the positive control and treatment groups, with the Ph-HAase-treated groups exhibiting extensive nuclear fragmentation, karyorrhexis, and lytic necrosis (Fig. 11). This is consistent with the previous results that Ph-HAase inhibited the growth of mouse melanoma. Robert & D’Arcy et al. [77, 78] analyzed the morphological characteristics of apoptosis, necrosis, and autophagy in various cell types, including B16F10 cells, and identified karyorrhexis and karyolysis as markers of apoptosis [78]. Fig. 11HE staining of C57 mouse tissues HE staining of C57 mouse tissues Conclusion The optimal fermentation conditions for Ph-HAase production by the P. heparinus were determined as follows: 2% peptone, 0.3% Na₂HPO₄·12 H₂O, 0.05% CaCl₂, an initial pH of 7.5–8.0, 4% inoculum size, 50%–60% loading volumes, a fermentation duration of 48 h, and a temperature of 15 °C. Following purification by affinity chromatography and ion exchange chromatography, the final specific activity of Ph-HAase reached 32.32 IU/mg, with a purification fold of 47.5. The molecular weight of Ph-HAase was determined to be 79.6 kDa via LC-MS. It exhibits the best degradation activity at 45℃ and pH 6.5. Additionally, this enzyme was found to promote apoptosis in B16F10 cells via the mitochondrial pathway, upregulating pro-apoptotic genes and proteins and downregulating anti-apoptotic genes and proteins. In vivo experiments confirmed that intratumoral injection of Ph-HAase can significantly inhibit tumor growth in a melanoma mouse model, and its effect is superior to that of the traditional chemotherapy drug 5-FU. This study discovered and characterized a previously unreported HAase derived from P. heparinus and demonstrated its potential as a drug for treating melanoma, providing experimental evidence for the development of new HAase enzyme sources. Data Availability Data will be made available on request. Supplementary Information Supplementary Material 1. Supplementary Material 1.